{"id":"W2569887051","doi":"10.1007/s12325-016-0467-6","title":"Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age","year":2017,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Cilag; Takeda Oncology; Pfizer; Takeda Pharmaceuticals International; Biogen; Bristol-Myers Squibb","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Internal medicine; Placebo; Adverse effect; Incidence (geometry); Clinical trial; Gastroenterology; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006510615,0.000105658,0.0001158456,0.00001932526,0.00006730227,0.0000219976,0.0001113786,0.00004509738,0.000005215286],"category_scores_gemma":[0.00006574291,0.0001014764,0.00001613278,0.00001281827,0.0002311414,0.0000222558,0.00004307601,0.00004361515,1.930203e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009229232,"about_ca_system_score_gemma":0.00002903169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001464737,"about_ca_topic_score_gemma":0.0003068262,"domain_scores_codex":[0.999359,0.00006326459,0.0001620798,0.0002249926,0.00006387624,0.0001268005],"domain_scores_gemma":[0.9995396,0.00001326024,0.00009923169,0.0002567653,0.00002326216,0.00006784605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02293219,0.0005041955,0.8409366,0.00009469841,0.00003979758,0.0001847096,0.0005986296,0.00005244924,0.007086648,0.0006106489,0.00009218637,0.1268672],"study_design_scores_gemma":[0.004905027,0.00009176002,0.9912426,0.00003006124,0.000002091542,1.720479e-7,0.00002092671,0.000008936042,0.00146799,0.0004215789,0.001694688,0.0001141418],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971768,0.00184576,0.000009539743,0.00001775414,0.0000420049,0.0003460758,0.0001045558,0.000002058832,0.0004554463],"genre_scores_gemma":[0.99376,0.005990634,0.00004602192,0.0000548292,0.00001731059,0.00002573936,0.0000570708,0.000009335574,0.00003909798],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.150306,"threshold_uncertainty_score":0.4138088,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006579731256089791,"score_gpt":0.2727616399943329,"score_spread":0.2661819087382431,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}